drugset / Trial / NCT02551497
Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects
RandomizedParallel-groupTriple-blindOther
Summary
This is a double-blind, randomised, placebo-controlled 3 period study to evaluate the interaction between a drug and CNV1014802 in healthy male and female subjects. It is planned to enrol 36 subjects.
Timeline
- Start
- 2015-04-30
- Primary completion
- 2016-08-16
- Completion
- 2016-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vixotrigine | Small molecule | — | — |
Indications
No indication recorded.